ArticlePathology oncology research : POR2015

p85 protein expression is associated with poor survival in HER2-positive patients with advanced breast cancer treated with trastuzumab.

Kitty Pavlakis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.